Working With Qualified Treatment Centers for Best Patient Outcomes

18 Jan 2023
Patient and Clinical Considerations Track

3:30pm Chair Introduction

Amritha Jaishankar, Executive Director, Cell and Gene Therapy Center, IQVIA


3:35pm Presentation: Clinical Centers as Partners in Advanced Cell Therapy Manufacturing – Roles & Challenges

  • Overview of clinical centers’ role as partners in manufacturing of advanced cell therapies
  • Review of clinical centers logistic challenges
  • Considerations for new approaches to standardization of advances cell therapies in the clinical environment

Ronit Slotky, Director, Cell Therapy Manufacturing Facility, Hackensack Medical Center


3:50pm Presentation: TBA

Phyllis I. Warkentin, Chief Medical Officer, Foundation for the Accreditation of Cellular Therapy (FACT)

4:05pm Presentation: Leveraging the Treatment Center Expertise for Cellular Therapy Product Commercialization

  • Simplifying the onboarding process
  • Pivoting the treatment center’s experience in cellular therapy and clinical trials to commercial products

Ramona Repaczki-Jones, Executive Director, Commercial Treatment Center Operations, Cell Therapy, Iovance


4:20pm  Closing Panel with Q&A

With all session participants



Amritha Jaishankar
Executive Director, Cell and Gene Therapy Center
Courtney Wells
Senior Vice President, Development Operations
Talaris Therapeutics
Phyllis I. Warkentin
Chief Medical Officer
Foundation for Accreditation Cellular Therapy (FACT)
Ramona Repaczki-Jones
Executive Director, Commercial Treatment Center Operations, Cell Therapy
Iovance Biotherapeutics Inc
Ronit Slotky
Director, Cell Therapy Manufacturing Facility
Hackensack University Medical Center